Literature DB >> 24519811

Inhibitory effects of juglanin on cellular senescence in human dermal fibroblasts.

Hyo Hyun Yang1, Kyoung Hwangbo, Ming Shan Zheng, Jong-Keun Son, Hwa Young Kim, Suk Hwan Baek, Hyung Chul Choi, So Young Park, Jae-Ryong Kim.   

Abstract

Cellular senescence contributes to tissue and organismal aging, tumor suppression and progress, tissue repair and regeneration, and age-related diseases. Thus, aging intervention might be a promising target for treatment and prevention of diverse age-related diseases. In the present study, we investigated whether juglanin purified from the crude extract of Polygonum aviculare exerted inhibitory activity against cellular senescence in human dermal fibroblasts (HDFs). Juglanin decreased senescence-associated β-galactosidase activity (SA-β-gal) and the level of reactive oxygen species in senescent cells induced by adriamycin treatment. Juglanin also repressed SA-β-gal activity in HDFs under replicative senescence. These results suggest that juglanin represses cellular senescence in HDFs and might be useful for the development of dietary supplements or cosmetics that alleviate tissue aging or age-related diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24519811     DOI: 10.1007/s11418-014-0817-0

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  23 in total

1.  Neuroprotective diarylheptanoids from the leaves and twigs of juglans sinensis against glutamate-induced toxicity in HT22 cells.

Authors:  Heejung Yang; Sang Hyun Sung; Jinwoong Kim; Young Choong Kim
Journal:  Planta Med       Date:  2010-12-14       Impact factor: 3.352

2.  Exploration of replicative senescence-associated genes in human dermal fibroblasts by cDNA microarray technology.

Authors:  In Kyung Yoon; Hyun Kyoung Kim; Yu Kyoung Kim; In-Hwan Song; Wankee Kim; Seongyong Kim; Suk-Hwan Baek; Jung Hye Kim; Jae-Ryong Kim
Journal:  Exp Gerontol       Date:  2004-09       Impact factor: 4.032

Review 3.  Cellular senescence: putting the paradoxes in perspective.

Authors:  Judith Campisi
Journal:  Curr Opin Genet Dev       Date:  2010-11-17       Impact factor: 5.578

Review 4.  Cellular senescence in cancer and aging.

Authors:  Manuel Collado; Maria A Blasco; Manuel Serrano
Journal:  Cell       Date:  2007-07-27       Impact factor: 41.582

5.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

Authors:  G P Dimri; X Lee; G Basile; M Acosta; G Scott; C Roskelley; E E Medrano; M Linskens; I Rubelj; O Pereira-Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

6.  Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice.

Authors:  Mariela Jaskelioff; Florian L Muller; Ji-Hye Paik; Emily Thomas; Shan Jiang; Andrew C Adams; Ergun Sahin; Maria Kost-Alimova; Alexei Protopopov; Juan Cadiñanos; James W Horner; Eleftheria Maratos-Flier; Ronald A Depinho
Journal:  Nature       Date:  2010-11-28       Impact factor: 49.962

7.  Two new C-glucosyl benzoic acids and flavonoids from Mallotus nanus and their antioxidant activity.

Authors:  Van Kiem Phan; Thi Mai Nguyen; Chau Van Minh; Huu Khoi Nguyen; Hai Dang Nguyen; Phuong Thao Nguyen; Xuan Cuong Nguyen; Hoai Nam Nguyen; Xuan Nhiem Nguyen; Yvan Vander Heyden; Joëlle Quetin-Leclercq; Gyo Nam Kim; Hae Dong Jang; Young Ho Kim
Journal:  Arch Pharm Res       Date:  2010-02-24       Impact factor: 4.946

8.  Interferon-gamma induces cellular senescence through p53-dependent DNA damage signaling in human endothelial cells.

Authors:  Kwang Seok Kim; Kyung Won Kang; Young Bae Seu; Suk-Hwan Baek; Jae-Ryong Kim
Journal:  Mech Ageing Dev       Date:  2008-11-21       Impact factor: 5.432

9.  Cytotoxic diarylheptanoids from the pericarps of walnuts (Juglans regia).

Authors:  Jun-Xi Liu; Duo-Long Di; Xiao-Ning Wei; Yin Han
Journal:  Planta Med       Date:  2008-05-21       Impact factor: 3.352

Review 10.  Four faces of cellular senescence.

Authors:  Francis Rodier; Judith Campisi
Journal:  J Cell Biol       Date:  2011-02-14       Impact factor: 10.539

View more
  8 in total

1.  Disruption of Robo2-Baiap2 integrated signaling drives cystic disease.

Authors:  Qinggang Li; Shaoyuan Cui; Qian Ma; Ying Liu; Hongyu Yu; GuangRui Geng; Ewud Agborbesong; Chongyu Ren; Kai Wei; Yingjie Zhang; Jurong Yang; Xueyuan Bai; Guangyan Cai; Yuansheng Xie; Xiaogang Li; Xiangmei Chen
Journal:  JCI Insight       Date:  2019-09-19

2.  Progressive slowdown/prevention of cellular senescence by CD9-targeted delivery of rapamycin using lactose-wrapped calcium carbonate nanoparticles.

Authors:  Raj Kumar Thapa; Hanh Thuy Nguyen; Jee-Heon Jeong; Jae Ryong Kim; Han-Gon Choi; Chul Soon Yong; Jong Oh Kim
Journal:  Sci Rep       Date:  2017-04-10       Impact factor: 4.379

3.  Juglanin suppresses fibrosis and inflammation response caused by LPS in acute lung injury.

Authors:  Ze-Wu Dong; Yu-Fang Yuan
Journal:  Int J Mol Med       Date:  2018-03-09       Impact factor: 4.101

4.  Juglanin ameliorates UVB‑induced skin carcinogenesis via anti‑inflammatory and proapoptotic effects in vivo and in vitro.

Authors:  Gui-Rong Hou; Kang Zeng; Hai-Mei Lan; Qi Wang
Journal:  Int J Mol Med       Date:  2018-03-29       Impact factor: 4.101

Review 5.  Senotherapeutics: emerging strategy for healthy aging and age-related disease.

Authors:  Eok-Cheon Kim; Jae-Ryong Kim
Journal:  BMB Rep       Date:  2019-01       Impact factor: 4.778

6.  Juglanin inhibits lung cancer by regulation of apoptosis, ROS and autophagy induction.

Authors:  Liang Chen; Ya-Qiong Xiong; Jing Xu; Ji-Peng Wang; Zi-Li Meng; Yong-Qing Hong
Journal:  Oncotarget       Date:  2017-09-28

Review 7.  Natural Products to Fight Cancer: A Focus on Juglans regia.

Authors:  Elena Catanzaro; Giulia Greco; Lucia Potenza; Cinzia Calcabrini; Carmela Fimognari
Journal:  Toxins (Basel)       Date:  2018-11-14       Impact factor: 4.546

8.  Juglanin administration protects skin against UVB‑induced injury by reducing Nrf2‑dependent ROS generation.

Authors:  Ying-Hui Kong; Su-Ping Xu
Journal:  Int J Mol Med       Date:  2020-04-24       Impact factor: 4.101

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.